Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 5123217, 11 pages
https://doi.org/10.1155/2018/5123217
Review Article

Mind-Body Therapies for African-American Women at Risk for Cardiometabolic Disease: A Systematic Review

1Department of Family and Community Health Nursing, Virginia Commonwealth University School of Nursing, 1100 E. Leigh St., P.O. Box 980567, Richmond, VA 23298, USA
2University of North Carolina Chapel Hill School of Nursing, 307 E. Carrington Hall, Campus Box 7460, Chapel Hill, NC 27599-7460, USA
3Tompkins-McCaw Library for the Health Sciences, Virginia Commonwealth University School of Nursing, 509 N. 12th Street, P.O. Box 980582, Richmond, VA 23298, USA

Correspondence should be addressed to Candace C. Johnson; ude.ucv@7mcnosnhoj

Received 23 May 2017; Accepted 4 December 2017; Published 26 February 2018

Academic Editor: Giuseppe Caminiti

Copyright © 2018 Candace C. Johnson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. A major determinant in cardiometabolic health is metabolic syndrome (MetS), a cluster of symptoms that portend the development of cardiovascular disease (CVD). As mind-body therapies are thought to help in lowering physiological and environmental CVD risk factors including blood pressure and psychological stress, they may also be beneficial for the primary prevention of CVD. Objectives. To synthesize and summarize existing knowledge on the effectiveness of mind-body therapies on MetS outcomes in African-American (AA) women, a US subpopulation at high risk for CVD. Search Methods. A systematic search of eight databases was conducted in order to identify published papers addressing the topic. We included trials involving AA adult women, ages 18–64, and we included RCTs that involved multifactorial interventions. Outcomes of interest were MetS, chronic disease, and CVD risk factors (blood pressure, blood lipids, blood glucose, BMI, waist circumference, and mental health domains). Two authors independently selected trials for inclusion, extracted data, and assessed risks of bias. Main Results. We identified five trials for inclusion in this review. One study reported outcomes associated with the full MetS symptom cluster. The included trials were small, short term, and at high risk of bias. All interventions lasted at least 6 weeks.